Carl Zeiss Intraocular Lens Implant Patent EP4213767A1

Carl Zeiss intraocular lens implant, EP4213767A1, published 1st Apr

High Definition and Extended Depth of Field Intraocular Lens

The European Patent Office granted Patent EP4076281A1 to Z Optics, Inc. for a high definition and extended depth of field intraocular lens design. The patent covers optical engineering innovations in intraocular lens technology and is designated for all 31 European Patent Convention member states.

STEM FOR ARTIFICIAL JOINT AND METHOD FOR MANUFACTURING SAME

The European Patent Office published patent EP4129242A1 for a stem component for artificial joints, assigned to Saga University and Kyocera Medical Corporation. The patent covers the design and manufacturing method for artificial joint stems. Protection extends across EU member states plus additional European countries designated in the filing.

Cephea Valve Delivery System - Heart Valve Replacement

The European Patent Office published EP4138729A2 for Cephea Valve Technologies, Inc., covering a delivery system for heart valve replacement. The patent application was filed with claims related to A61F 2/24 (heart valve prostheses) and A61M 25/01 (catheter placement). The patent designates all EU member states plus Switzerland, Norway, and Turkey.

Extracellular vesicles biomarkers neuromuscular disorders patent published

Extracellular vesicles biomarkers neuromuscular disorders patent published

RIKEN Patent - Paraprevotella Bacterium Inhibits Trypsin Activity

The European Patent Office published patent EP3851517A1, granting RIKEN exclusive rights in 34 designated member states to a composition containing Paraprevotella bacterium for inhibiting trypsin activity. The composition contains the bacterium as the active ingredient and covers therapeutic and industrial applications of the trypsin inhibitor.

Combination therapy for treating muscular dystrophy patent

The European Patent Office granted Solidus Biosciences Patent EP3893940A1 covering combination therapies for treating muscular dystrophy, including genetic, protein-based, and viral vector approaches. The patent, classified under IPC codes A61K 48/00 and C12N 15/113, designates all EU member states plus Switzerland, Norway, and Turkey. This patent grant establishes intellectual property rights that may affect freedom-to-operate for competing therapeutic development programs.

Simultaneous Gene Editing and Haploid Induction

The European Patent Office published patent application EP3899016A1 for Syngenta Crop Protection AG, covering simultaneous gene editing and haploid induction in plants. The invention involves methods for combining haploid induction with CRISPR-based gene editing to accelerate crop breeding. The patent names inventors Timothy Kelliher and Qiudeng Que, with priority classification in C12N 9/22 (nucleic acid enzymes) and related biotechnology IPC codes.

Exogenous protein-expressing microorganism and use thereof

The European Patent Office published patent EP3858995A2 granted to Medytox Inc. on April 1, 2026, covering an exogenous protein-expressing microorganism and its applications. The patent specifies designated states across EU member nations and multiple IPC classifications spanning therapeutic, nutritional, and pharmaceutical uses.

Google Machine Learning Temporal Residual Connections Patent

The European Patent Office published EP4232959A1, a Google patent for machine learning models with temporal residual connections designed to improve sequential data processing. The patent covers techniques for enhanced handling of time-series data using specialized neural network architectures.